Aarti Industries plans to raise up to ₹1,000 crore, with an EGM set for October 31, 2026. This move follows a leadership change and a strong Q1 FY27 performance, where revenue grew 41%. Investors are focusing on how the new management addresses rising working capital needs and potential equity dilution.
Aarti Industries is moving through a significant strategic shift as it prepares to raise up to ₹1,000 crore in fresh capital. The company has scheduled an Extraordinary General Meeting (EGM) for October 31, 2026, to seek shareholder approval for this fundraising. This financial exercise comes at a time of leadership change, with Suyog Kotecha officially taking over as the Managing Director and CEO effective October 1, 2026. The former promoter executive directors have moved into non-executive roles, marking a transition in the company's management structure.
Financial Performance and Operational Growth
The company’s recent performance shows a positive trend. In the first quarter of fiscal year 2027 (Q1 FY27), Aarti Industries reported a 41% year-on-year increase in revenue to ₹2,627 crore. Profit after tax also saw a substantial rise, growing 260% to ₹155 crore compared to the same period last year. This performance has been supported by increased export demand and the successful commissioning of Phase I at the Jhagadia site in Gujarat in September 2026. These new facilities are specifically designed to manufacture high-value, niche chemical products, aiming to move the company toward more profitable downstream integration.
Strategic Focus and Risks
While the company is expanding its high-value capacity, several factors require investor attention. The chemical sector is currently navigating geopolitical tensions that can cause raw material price fluctuations and supply chain disruptions. Furthermore, the company has seen an increase in its debtor days, which rose from 50.1 to 61.8 days in recent reporting. This change suggests that more money is currently tied up in day-to-day operations, requiring better working capital management.
Investors will be closely watching the upcoming EGM to understand the structure of the ₹1,000 crore fundraising. The method chosen—whether through debt or equity—will influence the company's future financial health. If the company chooses to issue new shares, it could lead to equity dilution, reducing the value of existing shares. If it opts for debt, the company’s interest burden will increase. The new management team faces the challenge of maintaining margin growth while managing these liquidity and capital allocation tasks effectively.
Moving forward, the primary monitorables for shareholders include the outcome of the October 31 vote, the specific use of the new funds, and whether the company can stabilize its working capital cycle in the coming quarters.